Elaborate Announces $10M in Funding to Modernize Lab Results

Elaborate’s technology offers doctors a way to contextualize health data and deliver clear, action-oriented communications to their patients Elaborate, the tool that doctors and their staff use to deliver contextualized, action-oriented lab results to patients, announced today it has raised $10 million in Seed funding. The funding round was led by Tusk Venture Partners, with participation from Founder Collective, Company Ventures, Bling Ventures, and Arkitekt Ventures, as well as renown investors such as Elliot Cohen (Pillpack, Amazon), Sara Wajnberg (Oscar), Scott Belsky (Behance, Adobe), and Sean and Peter Glass, MD (Advantia). Today, over 44% of patients getting routine bloodwork will receive at least one out-of-range value that is not clinically relevant or an immediate cause for concern, but causes the patient to call or message their practitioner for clarification. In the past, clinical practices have withheld results from patients to ease the burden of panicked patient calls and messages. However, the recent 21st Century Cures Act mandates the electronic release of all medical records to patients, including test results, without delay. While this mandate ensures patients have access to their own health data, it has unintended consequences for a doctor’s workload, skyrocketing the number of questions patients have about their lab results. Launched in 2021, Elaborate seamlessly integrates with a doctor’s existing electronic medical records (EMR...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Adobe Advantia Amazon Amy Esposito Arkitekt Ventures Behance Bling Ventures Company Ventures Digital Patient Communication Doctor-Patient Communication Elaborate Electronic Medical Records Elliot Source Type: blogs